4 things you missed from Day 4 of the Musk v. Altman trial

Day 4 of the Musk v. Altman trial centered on Elon Musk's testimony that xAI is "very small" and about one-tenth the size of OpenAI, while the judge cut off discussion of an AI "Terminator" scenario. Musk's money manager Jared Birchall testified that Musk made $38 million in donations to OpenAI across roughly 60 contributions, with cross-examination focusing on how those funds were intended to be used and on security arrangements. The next major witness is OpenAI president Greg Brockman, whose diary entries are being used to support Musk's claims about OpenAI's shift toward for-profit structures.

Analysis

The market read-through is less about legal liability and more about capital-allocation friction inside the AI stack. If the court materially validates a narrative that xAI is a sidecar rather than a true competitor, it reduces the odds of a near-term valuation reset for the public AI bellwethers; the real second-order effect is on how aggressively private capital keeps funding adjacent ventures when governance optics become litigious. That matters most for MSFT and GOOGL indirectly: a drawn-out trial could raise the discount rate on founder-led AI ecosystems, but it is unlikely to change enterprise spending patterns over the next quarter.

The more interesting risk is not the courtroom record itself, but the possibility that discovery surfaces communications around board intent, financing boundaries, or asset-sharing that complicate future transactions. That creates a tail risk for TSLA, because any renewed scrutiny of Musk’s overlapping ventures can force management distraction and create headline volatility, even if the economics are immaterial. In contrast, the open-ended AI capex cycle at MSFT and GOOGL should remain intact unless the case somehow impairs OpenAI’s distribution or partnership flexibility, which looks like a months-to-years issue rather than a days-to-weeks catalyst.

Contrarian angle: the consensus may be overpricing the trial as an OpenAI-versus-Musk binary when the real overhang is governance precedent for founder-controlled AI networks. If the judge narrows the case, the loser may be not OpenAI but the market’s willingness to assign premium multiples to opaque, vertically entangled AI structures. That makes this a relative-value event more than a directional one.

On the near-term tape, the biggest equity response is likely in TSLA, where incremental headline risk can suppress multiple expansion despite limited fundamental linkage. The setup favors using event-driven volatility around witness milestones rather than taking a big outright view on AI fundamentals.

Key Decisions for Investors

• Short-dated TSLA put spread into next week’s Brockman testimony: buy the 1-2 month 5-8% OTM put spread to monetize headline volatility; risk/reward favors a modest downside drift if cross-examination broadens governance optics.
• Long MSFT / short TSLA pair for 2-6 weeks: MSFT retains cleaner AI monetization with less founder-overhang, while TSLA is more exposed to distraction and multiple compression; target modest relative outperformance if trial headlines intensify.
• Avoid initiating fresh directional longs in GOOGL solely on this event; the litigation is more likely to affect sentiment than fundamentals, so any dip should be treated as a separate entry point only if broader AI spending weakens.
• For existing TSLA longs, hedge 25-35% of delta with puts through the next witness sequence; the risk is not earnings impairment but a temporary valuation de-rating from governance noise.
• Watch for a positive surprise in OpenAI-related governance clarity; if the judge narrows damages or removes officer-remedy language, consider covering TSLA hedges and fading the knee-jerk volatility as the market reverts to AI capex fundamentals.